235 related articles for article (PubMed ID: 16702190)
21. Ebselen as template for stabilization of A4V mutant dimer for motor neuron disease therapy.
Chantadul V; Wright GSA; Amporndanai K; Shahid M; Antonyuk SV; Washbourn G; Rogers M; Roberts N; Pye M; O'Neill PM; Hasnain SS
Commun Biol; 2020 Mar; 3(1):97. PubMed ID: 32139772
[TBL] [Abstract][Full Text] [Related]
22. Mitochondria in amyotrophic lateral sclerosis: a trigger and a target.
Dupuis L; Gonzalez de Aguilar JL; Oudart H; de Tapia M; Barbeito L; Loeffler JP
Neurodegener Dis; 2004; 1(6):245-54. PubMed ID: 16908975
[TBL] [Abstract][Full Text] [Related]
23. Depletion of reduced glutathione enhances motor neuron degeneration in vitro and in vivo.
Chi L; Ke Y; Luo C; Gozal D; Liu R
Neuroscience; 2007 Feb; 144(3):991-1003. PubMed ID: 17150307
[TBL] [Abstract][Full Text] [Related]
24. HoxB2 binds mutant SOD1 and is altered in transgenic model of ALS.
Zhai J; Lin H; Canete-Soler R; Schlaepfer WW
Hum Mol Genet; 2005 Sep; 14(18):2629-40. PubMed ID: 16079151
[TBL] [Abstract][Full Text] [Related]
25. Role of complement in motor neuron disease: animal models and therapeutic potential of complement inhibitors.
Woodruff TM; Costantini KJ; Taylor SM; Noakes PG
Adv Exp Med Biol; 2008; 632():143-58. PubMed ID: 19025120
[TBL] [Abstract][Full Text] [Related]
26. Focal loss of the glutamate transporter EAAT2 in a transgenic rat model of SOD1 mutant-mediated amyotrophic lateral sclerosis (ALS).
Howland DS; Liu J; She Y; Goad B; Maragakis NJ; Kim B; Erickson J; Kulik J; DeVito L; Psaltis G; DeGennaro LJ; Cleveland DW; Rothstein JD
Proc Natl Acad Sci U S A; 2002 Feb; 99(3):1604-9. PubMed ID: 11818550
[TBL] [Abstract][Full Text] [Related]
27. Effect of neuroprotective drugs on gene expression in G93A/SOD1 mice.
Ignacio S; Moore DH; Smith AP; Lee NM
Ann N Y Acad Sci; 2005 Aug; 1053():121-36. PubMed ID: 16179515
[TBL] [Abstract][Full Text] [Related]
28. Loss of the astrocyte glutamate transporter GLT1 modifies disease in SOD1(G93A) mice.
Pardo AC; Wong V; Benson LM; Dykes M; Tanaka K; Rothstein JD; Maragakis NJ
Exp Neurol; 2006 Sep; 201(1):120-30. PubMed ID: 16753145
[TBL] [Abstract][Full Text] [Related]
29. Respiration and ROS production in brain and spinal cord mitochondria of transgenic rats with mutant G93a Cu/Zn-superoxide dismutase gene.
Panov A; Kubalik N; Zinchenko N; Hemendinger R; Dikalov S; Bonkovsky HL
Neurobiol Dis; 2011 Oct; 44(1):53-62. PubMed ID: 21745570
[TBL] [Abstract][Full Text] [Related]
30. Mutant SOD1 causes motor neuron disease independent of copper chaperone-mediated copper loading.
Subramaniam JR; Lyons WE; Liu J; Bartnikas TB; Rothstein J; Price DL; Cleveland DW; Gitlin JD; Wong PC
Nat Neurosci; 2002 Apr; 5(4):301-7. PubMed ID: 11889469
[TBL] [Abstract][Full Text] [Related]
31. Ebselen by modulating oxidative stress improves hypoxia-induced macroglial Müller cell and vascular injury in the retina.
Tan SM; Deliyanti D; Figgett WA; Talia DM; de Haan JB; Wilkinson-Berka JL
Exp Eye Res; 2015 Jul; 136():1-8. PubMed ID: 25912997
[TBL] [Abstract][Full Text] [Related]
32. Inducible superoxide dismutase 1 aggregation in transgenic amyotrophic lateral sclerosis mouse fibroblasts.
Turner BJ; Lopes EC; Cheema SS
J Cell Biochem; 2004 Apr; 91(5):1074-84. PubMed ID: 15034941
[TBL] [Abstract][Full Text] [Related]
33. ALS-linked Cu/Zn-SOD mutation increases vulnerability of motor neurons to excitotoxicity by a mechanism involving increased oxidative stress and perturbed calcium homeostasis.
Kruman II; Pedersen WA; Springer JE; Mattson MP
Exp Neurol; 1999 Nov; 160(1):28-39. PubMed ID: 10630188
[TBL] [Abstract][Full Text] [Related]
34. Role of heat shock response and Hsp27 in mutant SOD1-dependent cell death.
Krishnan J; Lemmens R; Robberecht W; Van Den Bosch L
Exp Neurol; 2006 Aug; 200(2):301-10. PubMed ID: 16806187
[TBL] [Abstract][Full Text] [Related]
35. Mitochondrial dysfunction and its role in motor neuron degeneration in ALS.
Manfredi G; Xu Z
Mitochondrion; 2005 Apr; 5(2):77-87. PubMed ID: 16050975
[TBL] [Abstract][Full Text] [Related]
36. Transgenics, toxicity and therapeutics in rodent models of mutant SOD1-mediated familial ALS.
Turner BJ; Talbot K
Prog Neurobiol; 2008 May; 85(1):94-134. PubMed ID: 18282652
[TBL] [Abstract][Full Text] [Related]
37. SOD1 targeted to the mitochondrial intermembrane space prevents motor neuropathy in the Sod1 knockout mouse.
Fischer LR; Igoudjil A; Magrané J; Li Y; Hansen JM; Manfredi G; Glass JD
Brain; 2011 Jan; 134(Pt 1):196-209. PubMed ID: 21078595
[TBL] [Abstract][Full Text] [Related]
38. Induction of parkinsonism-related proteins in the spinal motor neurons of transgenic mouse carrying a mutant SOD1 gene.
Morimoto N; Nagai M; Miyazaki K; Ohta Y; Kurata T; Takehisa Y; Ikeda Y; Matsuura T; Asanuma M; Abe K
J Neurosci Res; 2010 Jun; 88(8):1804-11. PubMed ID: 20127819
[TBL] [Abstract][Full Text] [Related]
39. Selenite and ebselen supplementation attenuates D-galactose-induced oxidative stress and increases expression of SELR and SEP15 in rat lens.
Dai J; Zhou J; Liu H; Huang K
J Biol Inorg Chem; 2016 Dec; 21(8):1037-1046. PubMed ID: 27752786
[TBL] [Abstract][Full Text] [Related]
40. Motor neuron disease in transgenic mice with an H46R mutant SOD1 gene.
Sasaki S; Nagai M; Aoki M; Komori T; Itoyama Y; Iwata M
J Neuropathol Exp Neurol; 2007 Jun; 66(6):517-24. PubMed ID: 17549011
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
